| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| LIVNLivaNova PLC | 3.35B | 61.33 | 52.87 | 8.66% | -16.12% | -18.79% | 4.06% | 0.51 |
| ABTAbbott Laboratories | 216.14B | 124.30 | 16.27 | 4.59% | 31.88% | 27.26% | 2.94% | 0.32 |
| EWEdwards Lifesciences Corporation | 48.65B | 83.84 | 12.03 | 8.57% | 23.19% | 13.37% | 0.6% | 0.07 |
| AVRAnteris Technologies Global Corp. | 184.98M | 4.49 | -1.19 | -1.16% | -39.42% | -25.1% | 0.02 |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Sales/Revenue | 5.46M | 5.83M | 3.2M | 2.73M | 2.7M |
| Revenue Growth % | - | 0.07% | -0.45% | -0.15% | -0.01% |
| Cost of Goods Sold | 2.1M | 3.93M | 2.9M | 1.86M | 1.44M |
| COGS % of Revenue | 0.38% | 0.67% | 0.91% | 0.68% | 0.53% |
| Gross Profit | 3.36M | 1.91M | 298.38K | 876.8K | 1.27M |
| Gross Margin % | 0.62% | 0.33% | 0.09% | 0.32% | 0.47% |
| Gross Profit Growth % | - | -0.43% | -0.84% | 1.94% | 0.44% |
| Operating Expenses | 16.62M | 18.77M | 31.41M | 49.02M | 79.64M |
| OpEx % of Revenue | 3.05% | 3.22% | 9.81% | 17.92% | 29.46% |
| Selling, General & Admin | 2.63M | 9.14M | 15.21M | 17.05M | 0 |
| SG&A % of Revenue | 0.48% | 1.57% | 4.75% | 6.23% | - |
| Research & Development | 3.57M | 9.99M | 17.59M | 31.02M | 51.45M |
| R&D % of Revenue | 0.65% | 1.71% | 5.5% | 11.34% | 19.03% |
| Other Operating Expenses | 10.41M | -364.5K | -1.39M | 949.48K | 28.19M |
| Operating Income | -13.26M | -16.86M | -31.11M | -48.14M | -78.37M |
| Operating Margin % | -2.43% | -2.89% | -9.72% | -17.6% | -28.99% |
| Operating Income Growth % | - | -0.27% | -0.85% | -0.55% | -0.63% |
| EBITDA | -12.68M | -16.22M | -30.34M | -46.98M | -76.86M |
| EBITDA Margin % | -2.32% | -2.78% | -9.48% | -17.18% | -28.44% |
| EBITDA Growth % | - | -0.28% | -0.87% | -0.55% | -0.64% |
| D&A (Non-Cash Add-back) | 577.52K | 640.09K | 774.08K | 1.16M | 1.51M |
| EBIT | -14.63M | -16.14M | -29.92M | -46.7M | -78.37M |
| Net Interest Income | -300.64K | -965.64K | -438.33K | 360.97K | -82K |
| Interest Income | 0 | 68.55K | 210.38K | 428.06K | 0 |
| Interest Expense | 300.64K | 1.03M | 648.71K | 67.09K | 82K |
| Other Income/Expense | 1.48M | -310.48K | 550.48K | 1.38M | 2.4M |
| Pretax Income | -11.78M | -17.17M | -30.56M | -46.76M | -75.97M |
| Pretax Margin % | -2.16% | -2.95% | -9.55% | -17.1% | -28.1% |
| Income Tax | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1% | 1% | 1% | 0.98% | 1% |
| Net Income | -11.78M | -17.17M | -30.56M | -46.02M | -76.29M |
| Net Margin % | -2.16% | -2.95% | -9.55% | -16.83% | -28.22% |
| Net Income Growth % | - | -0.46% | -0.78% | -0.51% | -0.66% |
| Net Income (Continuing) | -11.78M | -17.17M | -30.56M | -46.76M | -75.97M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | -402.83K | -79K |
| EPS (Diluted) | -0.33 | -0.48 | -0.85 | -1.28 | -3.77 |
| EPS Growth % | - | -0.45% | -0.77% | -0.51% | -1.95% |
| EPS (Basic) | -0.33 | -0.48 | -0.85 | -1.28 | -3.77 |
| Diluted Shares Outstanding | 35.94M | 35.94M | 35.94M | 35.94M | 20.25M |
| Basic Shares Outstanding | 35.94M | 35.94M | 35.94M | 35.94M | 20.25M |
| Dividend Payout Ratio | - | - | - | - | - |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Total Current Assets | 6.24M | 18.75M | 12.24M | 24.22M | 74.65M |
| Cash & Short-Term Investments | 3.36M | 15.46M | 9.29M | 21.03M | 70.46M |
| Cash Only | 3.36M | 15.46M | 9.29M | 21.03M | 70.46M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 652.39K | 1.85M | 1.51M | 1.85M | 383K |
| Days Sales Outstanding | 43.63 | 115.94 | 172.72 | 246.29 | 51.72 |
| Inventory | 534.67K | 549.82K | 355.62K | 442.35K | 513K |
| Days Inventory Outstanding | 92.96 | 51.13 | 44.72 | 86.9 | 130.3 |
| Other Current Assets | 1.7M | 0 | 60.13K | 61.66K | 2.66M |
| Total Non-Current Assets | 3.51M | 2.68M | 3.75M | 6.31M | 6.05M |
| Property, Plant & Equipment | 1.87M | 1.92M | 3.14M | 5.48M | 5.86M |
| Fixed Asset Turnover | 2.91x | 3.04x | 1.02x | 0.50x | 0.46x |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.09M | 763.64K | 607.35K | 410.15K | 189K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 548.3K | 0 | 0 | 417.27K | 0 |
| Total Assets | 9.75M | 21.43M | 15.99M | 30.53M | 80.7M |
| Asset Turnover | 0.56x | 0.27x | 0.20x | 0.09x | 0.03x |
| Asset Growth % | - | 1.2% | -0.25% | 0.91% | 1.64% |
| Total Current Liabilities | 6.04M | 10.2M | 6.05M | 9.46M | 16.56M |
| Accounts Payable | 581.87K | 2.23M | 1.73M | 3.14M | 5.89M |
| Days Payables Outstanding | 101.16 | 207.27 | 217.17 | 616.67 | 1.5K |
| Short-Term Debt | 1.97M | 3.38M | 0 | 0 | 3K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.82M | 1.81M | 1.57M | 1.77M | 1.44M |
| Current Ratio | 1.03x | 1.84x | 2.02x | 2.56x | 4.51x |
| Quick Ratio | 0.94x | 1.78x | 1.97x | 2.51x | 4.48x |
| Cash Conversion Cycle | 35.42 | -40.2 | 0.27 | -283.48 | -1.31K |
| Total Non-Current Liabilities | 1.85M | 712.36K | 907.04K | 2.17M | 1.46M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 639.32K | 305.81K | 439.78K | 926.78K | 645K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.21M | 406.54K | 467.26K | 1.25M | 812K |
| Total Liabilities | 7.9M | 10.91M | 6.95M | 11.63M | 18.02M |
| Total Debt | 2.92M | 4.14M | 952.79K | 1.6M | 1.4M |
| Net Debt | -440.56K | -11.32M | -8.34M | -19.43M | -69.06M |
| Debt / Equity | 1.57x | 0.39x | 0.11x | 0.08x | 0.02x |
| Debt / EBITDA | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - |
| Interest Coverage | -44.11x | -16.30x | -47.96x | -717.55x | -955.76x |
| Total Equity | 1.86M | 10.52M | 9.03M | 18.9M | 62.68M |
| Equity Growth % | - | 4.67% | -0.14% | 1.09% | 2.32% |
| Book Value per Share | 0.05 | 0.29 | 0.25 | 0.53 | 3.09 |
| Total Shareholders' Equity | 1.86M | 10.52M | 9.03M | 19.3M | 62.76M |
| Common Stock | 106.97M | 141.47M | 169.79M | 217.33M | 4K |
| Retained Earnings | -103.91M | -123.51M | -154.07M | -200.1M | -276.39M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.2M | -7.75M | -9.94M | -9.56M | -10.89M |
| Minority Interest | 0 | 0 | 0 | -402.83K | -79K |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Cash from Operations | -11.08M | -14.44M | -29.42M | -34.63M | -61.24M |
| Operating CF Margin % | -2.03% | -2.48% | -9.19% | -12.66% | -22.66% |
| Operating CF Growth % | - | -0.3% | -1.04% | -0.18% | -0.77% |
| Net Income | -11.78M | -17.17M | -30.56M | -46.76M | -76.29M |
| Depreciation & Amortization | 1.01M | 640.09K | 774.08K | 1.16M | 1.97M |
| Stock-Based Compensation | 323.98K | 254.85K | 2.94M | 5.76M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -6.01M | 861.55K | -817.14K | 1.23M | 14.06M |
| Working Capital Changes | 5.38M | 976.4K | -1.75M | 3.99M | -982K |
| Change in Receivables | 4.53M | 85.45K | -533.8K | -345.01K | -911K |
| Change in Inventory | 862.78K | -15.71K | 194.2K | -86.72K | -71K |
| Change in Payables | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 5.99M | -886.07K | -992.57K | -2.58M | -2.28M |
| Capital Expenditures | -222.45K | -572.87K | -1.57M | -2.39M | -2.27M |
| CapEx % of Revenue | 0.04% | 0.1% | 0.49% | 0.87% | 0.84% |
| Acquisitions | - | - | - | - | - |
| Investments | - | - | - | - | - |
| Other Investing | 6.21M | -1.4K | 582.2K | 19.59K | -14K |
| Cash from Financing | 1.46M | 27.42M | 23.27M | 49.34M | 112.83M |
| Debt Issued (Net) | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - |
| Other Financing | 1.74M | -1.23M | -1.05M | -2.68M | 115.07M |
| Net Change in Cash | - | - | - | - | - |
| Free Cash Flow | -11.3M | -15.02M | -31.08M | -37.03M | -63.51M |
| FCF Margin % | -2.07% | -2.58% | -9.71% | -13.54% | -23.5% |
| FCF Growth % | - | -0.33% | -1.07% | -0.19% | -0.72% |
| FCF per Share | -0.31 | -0.42 | -0.86 | -1.03 | -3.14 |
| FCF Conversion (FCF/Net Income) | 0.94x | 0.84x | 0.96x | 0.75x | 0.80x |
| Interest Paid | 203.2K | 50.27K | 33.4K | 38.47K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | -634.53% | -277.38% | -312.54% | -329.54% | -187.03% |
| Return on Invested Capital (ROIC) | - | -4070.26% | - | -45271.86% | - |
| Gross Margin | 61.53% | 32.68% | 9.32% | 32.06% | 46.84% |
| Net Margin | -215.78% | -294.5% | -954.91% | -1682.81% | -2822.46% |
| Debt / Equity | 1.57x | 0.39x | 0.11x | 0.08x | 0.02x |
| Interest Coverage | -44.11x | -16.30x | -47.96x | -717.55x | -955.76x |
| FCF Conversion | 0.94x | 0.84x | 0.96x | 0.75x | 0.80x |
| Revenue Growth | - | 6.83% | -45.1% | -14.56% | -1.16% |
Anteris Technologies Global Corp. (AVR) reported $2.1M in revenue for fiscal year 2024. This represents a 61% decrease from $5.5M in 2020.
Anteris Technologies Global Corp. (AVR) saw revenue decline by 1.2% over the past year.
Anteris Technologies Global Corp. (AVR) reported a net loss of $84.3M for fiscal year 2024.
Anteris Technologies Global Corp. (AVR) has a return on equity (ROE) of -187.0%. Negative ROE indicates the company is unprofitable.
Anteris Technologies Global Corp. (AVR) had negative free cash flow of $79.4M in fiscal year 2024, likely due to heavy capital investments.